↓ Skip to main content

Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke

Overview of attention for article published in Frontiers in Neurology, January 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
315 Dimensions

Readers on

mendeley
295 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
Published in
Frontiers in Neurology, January 2013
DOI 10.3389/fneur.2013.00032
Pubmed ID
Authors

Shaheen E. Lakhan, Annette Kirchgessner, Deborah Tepper, Aidan Leonard

Abstract

Ischemic stroke continues to be one of the most challenging diseases in translational neurology. Tissue plasminogen activator (tPA) remains the only approved treatment for acute ischemic stroke, but its use is limited to the first hours after stroke onset due to an increased risk of hemorrhagic transformation over time resulting in enhanced brain injury. In this review we discuss the role of matrix metalloproteinases (MMPs) in blood-brain barrier (BBB) disruption as a consequence of ischemic stroke. MMP-9 in particular appears to play an important role in tPA-associated hemorrhagic complications. Reactive oxygen species can enhance the effects of tPA on MMP activation through the loss of caveolin-1 (cav-1), a protein encoded in the cav-1 gene that serves as a critical determinant of BBB permeability. This review provides an overview of MMPs' role in BBB breakdown during acute ischemic stroke. The possible role of MMPs in combination treatment of acute ischemic stroke is also examined.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 295 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Hong Kong 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 291 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 59 20%
Student > Bachelor 43 15%
Student > Master 38 13%
Researcher 33 11%
Student > Doctoral Student 14 5%
Other 43 15%
Unknown 65 22%
Readers by discipline Count As %
Neuroscience 59 20%
Medicine and Dentistry 47 16%
Agricultural and Biological Sciences 38 13%
Biochemistry, Genetics and Molecular Biology 32 11%
Pharmacology, Toxicology and Pharmaceutical Science 11 4%
Other 37 13%
Unknown 71 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 March 2023.
All research outputs
#20,744,283
of 25,483,400 outputs
Outputs from Frontiers in Neurology
#9,276
of 14,668 outputs
Outputs of similar age
#229,340
of 289,433 outputs
Outputs of similar age from Frontiers in Neurology
#102
of 210 outputs
Altmetric has tracked 25,483,400 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 14,668 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.5. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 289,433 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 210 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.